World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
54774
World Ranking
12888
National Ranking
6589

Overview

David B. Badesch is affiliated with the University of Colorado Denver in the United States. Their research primarily focuses on Medicine, with extensive work in the subfields of Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Hepatology, Genetics, and Epidemiology.

The scientist's main topics of study cover a variety of areas including Pulmonary Hypertension Research and Treatments, Liver Disease and Transplantation, Cardiovascular Issues in Pregnancy, Cardiovascular Function and Risk Factors, Vascular Anomalies and Treatments, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, and Heart Failure Treatment and Management.

David B. Badesch has contributed to multiple recent papers, including:

  • "Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension," 2023, New England Journal of Medicine
  • "Sotatercept for the Treatment of Pulmonary Arterial Hypertension," 2021, New England Journal of Medicine
  • "Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry," 2022, Journal of the American Heart Association
  • "Definition, classification and diagnosis of pulmonary hypertension," 2024, European Respiratory Journal
  • "Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial," 2021, American Journal of Respiratory and Critical Care Medicine

Their frequent coauthors include:

  • Marc Humbert
  • Teresa De Marco
  • Robert P. Frantz
  • Jeffrey S. Sager
  • Marius M. Hoeper

The venues where David B. Badesch most often publishes are:

  • Pulmonary Circulation
  • CHEST Journal
  • European Respiratory Journal
  • American Journal of Respiratory and Critical Care Medicine
  • UNC Libraries

Best Publications

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Bosentan therapy for pulmonary arterial hypertension.

    Lewis J. Rubin;David B. Badesch;Robyn J. Barst;Nazzareno Galiè

  • A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

    Robyn J. Barst;Lewis J. Rubin;Walker A. Long;Michael D. McGoon

  • Sildenafil citrate therapy for pulmonary arterial hypertension.

    Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst

  • Definitions and diagnosis of pulmonary hypertension

    Marius M Hoeper;Harm Jan Bogaard;Robin Condliffe;Robert Frantz

  • Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

    Richard N Channick;Gérald Simonneau;Olivier Sitbon;Ivan M Robbins

  • Predicting Survival in Pulmonary Arterial Hypertension Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)

    Raymond L. Benza;Dave P. Miller;Mardi Gomberg-Maitland;Robert P. Frantz

  • Diagnosis and Assessment of Pulmonary Arterial Hypertension

    David B. Badesch;Hunter C. Champion;Miguel Angel Gomez Sanchez;Marius M. Hoeper

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

    David B. Badesch;Victor F. Tapson;Michael D. McGoon;Bruce H. Brundage

  • Ambrisentan for the Treatment of Pulmonary Arterial Hypertension Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

    Nazzareno Galiè;Horst Olschewski;Ronald J. Oudiz;Fernando Torres

  • Pulmonary Arterial Hypertension : Baseline Characteristics From the REVEAL Registry

    David B. Badesch;Gary E. Raskob;C. Greg Elliott;Abby M. Krichman

  • Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines

    David B. Badesch;Steve H. Abman;Gregory S. Ahearn;Robyn J. Barst

  • An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

    Raymond L. Benza;Dave P. Miller;Robyn J. Barst;David B. Badesch

  • Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension

    Rubin M. Tuder;Carlyne D. Cool;Mark W. Geraci;Jun Wang

  • Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

    R. M. Tuder;B. Groves;D. B. Badesch;N. F. Voelkel

  • Beraprost therapy for pulmonary arterial hypertension

    Robyn J. Barst;Michael McGoon;Vallerie McLaughlin;Victor Tapson

  • Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

    Vallerie V. McLaughlin;Ronald J. Oudiz;Adaani Frost;Victor F. Tapson

  • Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized Trial

    Ge rald Simonneau;Lewis J. Rubin;Nazzareno Galie;Robyn J. Barst

  • Bosentan therapy for pulmonary arterial hypertension

    L.J. Rubin;D.B. Badesch;R.J. Barst

Frequent Co-Authors

Lewis J. Rubin
Lewis J. Rubin University of California, San Diego
Robyn J. Barst
Robyn J. Barst Columbia University
Victor F. Tapson
Victor F. Tapson Duke University
Nazzareno Galiè
Nazzareno Galiè University of Bologna
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Norbert F. Voelkel
Norbert F. Voelkel Virginia Commonwealth University
Olivier Sitbon
Olivier Sitbon University of Paris-Saclay
Marc Humbert
Marc Humbert University of Paris-Saclay
Anne Keogh
Anne Keogh University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine but seeking alternative or related pathways, a variety of online degrees can lead to rewarding healthcare careers. Many students opt for routes that offer flexibility and faster entry into the workforce. For instance, nursing schools that don't require teas or hesi exams can make the admissions process smoother for aspiring nurses, eliminating some common testing barriers.

Healthcare administration is another attractive option, with programs allowing you to study from anywhere. Explore the best online healthcare administration degree programs to fast-track your career in healthcare management.

For those already holding a nursing credential, bridge programs may be the next logical step. The asn to nurse practitioner programs provide a seamless pathway from associate to advanced practice roles.

Additionally, public health and nutrition are crucial in medical fields. Consider earning your credentials through online degrees in nutrition to unlock diverse clinical, community, or wellness career opportunities.

Each of these pathways can serve as a stepping stone within the ever-growing U.S. healthcare sector.

Best Scientists Citing David B. Badesch

Trending Scientists

Recently Published Articles